Хайлтын үр дүнгүүд - Andreas Erhardt
- 15-н 1 - 15 үр дүнгүүдийг харуулж байна
-
1
-
2
-
3
-
4
-
5
-
6
HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis -н Andreas Erhardt, Andrea Maschner-Olberg, Claudia Mellenthin, Günther Kappert, Ortwin Adams, Andreas Donner, R. Willers, Claus Niederau, Dieter Häussinger
Хэвлэсэн 2003Artigo -
7
-
8
Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase -н Erwin Daniel Brenndörfer, Juliane Karthe, Lars Frelin, Patricia Cebula, Andreas Erhardt, Jan Schulte Am Esch, Hartmut Hengel, Ralf Bartenschlager, Matti Sällberg, Dieter Häussinger, Johannes G. Bode
Хэвлэсэн 2009Artigo -
9
Development and evaluation of a baseline‐event‐anticipation score for hepatitis delta -н B. Calle Serrano, Anika Großhennig, María Homs, Benjamin Heidrich, Andreas Erhardt, Katja Deterding, Jerzy Jaroszewicz, Birgit Bremer, Armin Koch, Markus Cornberg, Michael P. Manns, Marı́a Buti, Heiner Wedemeyer
Хэвлэсэн 2014Artigo -
10
Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients -н Holger Hinrichsen, Yves Benhamou, Heiner Wedemeyer, Markus Reiser, Roel Sentjens, José Luís Calleja, Xavier Forns, Andreas Erhardt, Jens Crönlein, Ricardo L. Chaves, Chan‐Loi Yong, Gerhard Nehmiz, Gerhard Steinmann
Хэвлэсэн 2004Artigo -
11
Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta -н Heiner Wedemeyer, Cihan Yurdaydın, George Ν. Dalekos, Andreas Erhardt, Yılmaz Çakaloğlu, Halil Değertekin, Selım Gürel, Stefan Zeuzem, Kalliopi Zachou, Hakan Bozkaya, Armin Koch, C.‐Thomas Bock, Hans Peter Dienes, Michael P. Manns
Хэвлэсэн 2011Artigo -
12
Aktualisierung der S 3-Leitlinie zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion -н Markus Cornberg, Ulrike Protzer, J. Petersen, Heiner Wedemeyer, Thomas Berg, Wolfgang Jilg, Andreas Erhardt, Stéfan Wirth, Christoph Sarrazin, Matthias Dollinger, Peter Schirmacher, Katarina Dathe, I. Kopp, Stefan Zeuzem, Wolfram H. Gerlich, Michael P. Manns
Хэвлэсэн 2011Artigo -
13
Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta -н Benjamin Heidrich, Cihan Yurdaydın, Gökhan Kabaçam, Boris A. Ratsch, Kalliopi Zachou, Birgit Bremer, George Ν. Dalekos, Andreas Erhardt, Fehmı Tabak, Kendal Yalçın, Selım Gürel, Stefan Zeuzem, Markus Cornberg, C.‐Thomas Bock, Michael P. Manns, Heiner Wedemeyer
Хэвлэсэн 2014Artigo -
14
Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment -н Andreas Erhardt, Katja Deterding, Yves Benhamou, Markus Reiser, Xavier Forns, Stanislas Pol, José Luís Calleja, Susanne Ross, Hans Christian Spangenberg, Javier García‐Samaniego, Michael Fuchs, Jaime Enríquez, Johannes Wiegand, Jerry O. Stern, K. Wu, George Kukolj, Martin Marquis, Pierre L. Beaulieu, Gerhard Nehmiz, Jürgen Steffgen
Хэвлэсэн 2009Artigo -
15
Anti-HDV IgM as a Marker of Disease Activity in Hepatitis Delta -н A. Wranke, Benjamin Heidrich, Stefanie Ernst, Beatriz Calle Serrano, Florin Alexandru Căruntu, Manuela Curescu, Kendal Yalçın, Selım Gürel, Stefan Zeuzem, Andreas Erhardt, Stefan Lüth, George Papatheodoridis, Birgit Bremer, Judith Stift, Jan Grabowski, J. Kirschner, Kerstin Port, Markus Cornberg, Christine S. Falk, Hans‐Peter Dienes, Svenja Hardtke, Michael P. Manns, Cihan Yurdaydın, Heiner Wedemeyer
Хэвлэсэн 2014Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Internal medicine
Gastroenterology
Virus
Virology
Cirrhosis
Hepatitis B virus
Immunology
Biology
HBsAg
Hepatitis C virus
Hepatitis B
Hepatitis C
Gene
Hepatitis D
Interferon
Liver disease
Pharmacology
Adefovir
Adverse effect
Alpha interferon
Alternative medicine
Biochemistry
Cell biology
Cohort
Computer science
Disease
Environmental health
Fibrosis
Genetics